We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
3426
DELISTED
Myovant Sciences Ltd.
MYOV
-56,200
Closed -$1.52M
WPCB
3427
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
-1,732,872
Closed -$17.5M
SVFB
3428
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
-121,610
Closed -$1.23M
ESM.WS
3429
CALL
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
-331,114
Closed -$3.34M
WPCA
3430
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
-603,620
Closed -$6.1M
ESM
3431
DELISTED
ESM Acquisition Corporation
ESM
-1,497,129
Closed -$15.1M
FRSG
3432
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
-994,257
Closed -$9.99M
HERAW
3433
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
-575,994
Closed -$5.83M
HERA
3434
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
-1,275,686
Closed -$12.9M
FRSGW
3435
CALL
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
-135,878
Closed -$1.37M
LION
3436
DELISTED
Lionheart III Corp Class A Common Stock
LION
-255,415
Closed -$2.6M
LOKM.WS
3437
CALL
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
-49,996
Closed -$502K
LOKM
3438
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
-856,639
Closed -$8.61M
CNCE
3439
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-29,030
Closed -$170K
MLAI
3440
DELISTED
McLaren Technology Acquisition Corp. Class A Common Stock
MLAI
-978,301
Closed -$9.99M
FTEV
3441
DELISTED
FinTech Evolution Acquisition Group
FTEV
-1,289,141
Closed -$13M
EBACW
3442
CALL
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
-36,056
Closed -$364K
EBAC
3443
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
-453,992
Closed -$4.59M
IBER.WS
3444
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
-224,997
Closed -$2.27M
IBER
3445
DELISTED
Ibere Pharmaceuticals
IBER
-539,807
Closed -$5.45M
RFP
3446
DELISTED
Resolute Forest Products Inc.
RFP
-281,576
Closed -$6.08M
RNERW
3447
CALL
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
-330,000
Closed -$4.12M
COUP
3448
DELISTED
Coupa Software Incorporated
COUP
-57,115
Closed -$4.52M
ABGI
3449
DELISTED
ABG Acquisition Corp. I
ABGI
-683,660
Closed -$6.9M
CPAQW
3450
CALL
DELISTED
Counter Press Acquisition Corporation Warrant
CPAQW
-99,998
Closed -$1.03M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.